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ABSTRACT The quantitative analysis of the mobile high-energy phosphorus metabolites in isovolumic Langendorff-
perfused rabbit hearts has been performed by 31P NMR utilizing rapid pulse repetition to optimize sensitivity. Absolute
quantification required reference to an external standard, determination of differential magnetization saturation and
resonance peak area integration by Lorentzian lineshape analysis. Traditionally accepted hemodynamic indices
(LVDP, dp/dt) and biochemical indices (lactate, pyruvate) of myocardial function were measured concomitantly with
all NMR determinations. Hemodynamically and biochemically competent Langendorff-perfused rabbit hearts were
found to have intracellular PCr, ATP, GPC, and Pi concentrations of 14.95 ± 0.25, 8.08 ± 0.13, 5.20 ± 0.58 and 2.61 ±
0.47 mM respectively. Intracellular pH was 7.03 ± 0.01. Cytosolic ADP concentration was derived from a creatine
kinase equilibrium model and determined to be -36 ,uM. Reduction of perfusate flow from 20 to 2.5 ml/min
demonstrated statistically significant decreases in PCr, ATP, and pH as well as an increase in Pi that correlated closely
with the independent hemodynamic and biochemical indices of myocardial function. The decrease in ATP and PCr
concentrations precisely matched the increase in Pi during reduced flow. These results constitute the first quantitative
determination of intracellular metabolite concentrations by 3'P NMR in intact rabbit myocardium under physiologic
and low flow conditions.
INTRODUCTION
The detailed study of biochemical regulatory mechanisms
and their time dependent response to physiological pertur-
bations is greatly facilitated through quantification of
intracellular metabolite concentrations utilizing a nonde-
structive dynamic technique such as NMR spectroscopy.
Although 31P NMR analysis of intact tissues has become a
rapidly expanding field of biomedical research (1 and
references therein) the ability ofNMR to provide absolute,
as opposed to relative, mobile metabolite concentrations
has, in general, not been realized. Determination of abso-
lute metabolite concentrations requires integration of full
resonance lineshapes, analysis of magnetization saturation
and, ultimately, comparison with an external standard.
NMR spectroscopy has been used in conjunction with
several perfused heart models to examine myocardial
response to a variety of physiologic perturbations. How-
ever, in the main, these studies have routinely expressed
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the observed metabolic alterations in terms of resonance
peak heights or peak height ratios without consideration of
full resonance lineshape integration or differential magne-
tization saturation. Furthermore, the heart perfusion pro-
tocols have often employed nonphysiologic perturbations
such as the induction of anesthesia and anticoagulation
prior to heart excision or have utilized nonphysiologic
perfusion media (e.g., inclusion of EDTA or the absence of
insulin and/or inorganic phosphate in the perfusate). The
lack of strict hemodynamic control during the entire
experimental period (e.g., cardiac pacing and ventricular
preload) has additionally complicated interpretation of
experimental results. Futhermore, most studies have
employed zero flow (e.g., global ischemia) to simulate
ischemia that differs markedly from the in vivo situation
where residual flow is present in the ischemic zone through
the collateral circulation. Finally, previous NMR investi-
gations have not correlated independent hemodynamic and
biochemical indices of myocardial function with quantita-
tive alterations in intracellular 31P metabolite concentra-
tions and intracellular pH.
The present study utilizes 31P NMR rapid pulse repeti-
tion methodology with subsequent magnetization satura-
tion correction to quantify intracellular concentrations of
$1.00 803
phosphorus metabolites in hemodynamically and biochem-
ically competent isovolumic Langendorif-perfused rabbit
hearts under control and low flow conditions. The perfu-
sion model and experimental protocol employed avoid the
difficulties mentioned above. This investigation demon-
strates the excellent correlation of NMR derived metabo-
lite concentrations with other independent indices of myo-
cardial function measured concomitantly during theNMR
experiment. These correlations validate the 31P NMR
experiment as a sensitive monitor of myocardial compe-
tence and provide quantitative data for future metabolic
studies of intact myocardium.
MATERIAL AND METHODS
NMR Spectroscopy
A laboratory-built NMR probe based on modification of designs from the
University of Oxford group of Radda, Gadian, and coworkers (2) was
constructed to accommodate 4-7 g rabbit hearts in a vertical orientation
(Fig. 1, see caption for details). The sample chamber had a 25 mm bore to
avoid compression of the heart. A two turn Helmholtz style foil rf coil (30
mm diameter x 40 mm height), designed according to the optimized
parameters of Hoult (3), was employed in the single-coil configuration
(31P 900 pulse width 85 As at 100 W using 150 mM KCI with a point test
sample of 85% H3PO4 in the coil center).
Experiments were performed at 80.98 MHz on a CXP 200 spectrome-
ter (Bruker Instruments, Inc., Billerica, MA) in the absence of proton
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FIGURE I NMR probe for quantification of phosphorus metabolites in
the perfused rabbit heart at 80.98 MHz. (A) thermocouple assembly; (B)
rf input; (C) heat exchanger for input perfusate; (D) perfusate input; (E)
rf trap on pacing input to isolate the DC stimulator from the NMR rf
circuitry; (F) brass spacer rings for probe height adjustment; (G)
copper-coated glass epoxy printed circuit board housing for electronics,
grounding and tube segregation; (H) one of three air jets used to circulate
warm air around the sample chamber; (I) 55 gm foil Helmholtz NMR
coil; (J) sample chamber; (K) Langendorff-perfused heart; (L) addi-
tional rf tank traps for DC stimulator isolation; (M) pulmonary arterial
cannula; (N) balloon-tipped catheter for pressure measurements; (0)
perfusate input cannula-bubble trap.
decoupling. To optimize signal-to-noise (4) an acquisition time slightly in
excess of 3T for phosphocreatine (PCr), the resonance with the longest
T* relaxation time, was used with a 100 pulse without additional
relaxation delays. Magnetic field homogeneity was optimized by shim-
ming on the proton free induction decay through the 31P rf coil (5).
Spin-lattice relaxation times (T,) were determined from peak intensity
(height) measurements using the BASH saturation recovery technique
(6, 7) with evolution period cycling. Experimentally determined magneti-
zation saturation factors were obtained by comparison of spectra acquired
under the above rapid repetition conditions with spectra acquired under
slow repetition conditions where a 25 s relaxation delay was employed
(>4 x longest measured metabolite T,, that of glycerophosphorylcholine,
GPC) with a 900 pulse width. All chemical shifts are reported relative to
PCr as 0.0 ppm using the IUPAC recommended convention (8).
Rabbit Heart Perfusion
2-3 kg male New Zealand white rabbits were stunned and killed by
cervical dislocation. No additional anesthesia or blood anticoagulants
were employed. The heart was rapidly excised and the aorta cannulated
for retrograde perfusion with (EDTA free) Krebs-Henseleit perfusion
medium (NaCl 118 mM, KCI 5.0 mM, CaCl2 2.5 mM, MgSO4 0.6 mM,
KH2PO4 1.2 mM, dextrose 10 mM, NaHCO3 24 mM, Insulin 70 ju/ml).
The perfusate was oxygenated with 95:5% oxygen/carbon dioxide and
delivered at a flow rate of 20 ml/min. The inferior and superior venae
cavae and pulmonary veins were ligated and the pulmonary artery was
cannulated to allow collection and analysis of the coronary venous
effluent. Two rf-isolated copper pacing leads were sutured to the right
ventricle and the heart was paced at a rate of 180 beats/min throughout
all experiments. A balloon-tipped catheter was placed into the left
ventricle via the left atrial appendage which provided a constant preload
of 8-12 mm Hg and allowed continuous monitoring of heart rate, left
ventricular developed pressure (LVDP) and the first derivative of the
pressure (dp/dt). The heart was placed in the NMR probe and additional
perfusion medium was added to fill the sample tube to improve spectral
resolution. The entire procedure took 15-20 min.
Criteria for inclusion in the study were based on spectral, metabolic,
and hemodynamic parameters. Hearts with initial spectra showing peak
height ratios of PCr/ATP > 2, ATP/total inorganic phosphate >1.5,
lactate concentration in the effluent <2 mg % and left ventricular pulse
pressure >60 mm Hg were included in the study. The NMR indices were
never the sole determinant for inclusion. -10-15% of all hearts perfused
were rejected according to the above criteria.
Data Analyses
A capillary tube containing 1 M hexachlorocyclotriphosphazene (trimer)
in C6D6 with 62 mM chromium acetylacetonate was mounted on the inner
side of the sample chamber and used as an intensity reference standard as
previously described (9). This intensity standard was calibrated by
comparison against known concentrations of NaH2PO4 solutions in 150
mM KCI in various-sized spherical glass chambers centered in the NMR
sample holder and surrounded by 150 mM KCI solution. In all cases, the
electrical damping characteristics of the calibrating samples were similar
to those of the perfused heart preparation.
An acquisition time (70 ms) 2 3T * for PCr ensured that all resonance
lineshapes were not distorted, as other metabolite T* values were
substantially shorter. All free induction decays were zero filled to 2,048
total data points prior to Fourier transformation.
The Lorentzian lineshape resulting from a first order single exponential
decay results in substantial signal intensity in the wings of the peak, far
from the center of the resonance. Levy and coworkers have stressed the
need for substantial integration limits in accurately determining NMR
resonance peak areas (10). Weiss and Ferretti (I 1) have further shown
that, in cases of limited signal-to-noise, a Lorentzian lineshape analysis
(curve fit and analytical-closed form-area determination) can provide
increased accuracy over digital integration techniques. In cases where
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resonance lines overlap (i.e., PCr and -y-phosphate of ATP) a lineshape
analysis can be used to obtain individual peak areas. For purposes of
quantitative analysis herein, various regions of the 31p spectrum were fit
to a sum of Lorentzian lines plus a single straight line by a nonlinear least
squares fitting routine using a finite difference Levenberg Marquardt
algorithm run on a VAX 11/780 computer (Digital Equipment Corp.,
Maynard, MA). Inclusion of a straight line in the lineshape analysis was
found to provide an excellent first order correction to baseline nonideali-
ties.
The resonance from the ,-phosphate of ATP (taken to be unique for
ATP) was fit to a single Lorentzian line while the peaks due to PCr and
the y-phosphate of ATP were fit to two Lorentzian lines. The spectral
region containing resonances from phosphomonoesters (PME), inorganic
phosphate (Pi), and GPC was fit to from three to five Lorentzian lines,
depending on the apparent number of peaks present. Concentrations
measured directly herein for this spectral region are those of total Pi
(intra- and extracellular), and GPC. Since the lineshape and resolution of
the PME spectral region was poorly defined (especially during reduced
flow) no quantitative results are reported for it. Because of signal-to-noise
and resolution limitations, both Pi and GPC quantification was performed
on spectra representing the sum of three time blocks, namely 4-16 min
(control period), 20-32 (reduced flow), and 36-48 min (reflow).
The chemical shift of Pi with respect to PCr (b.) as a function ofpH was
determined utilizing a physiologic solution (KCI 150 mM, KH2PO4 20
mM, PCr 10 mM, ATP 5 mM, MgCl2 9.25 mM) at 370C. These data
were combined with previously obtained values (Ackerman, J. J. H.,
unpublished results; 12) and fitted to the Henderson-Hasselbach/chemi-
cal-shift expression, Eq. 1 (13), resulting in pK = 6.79, 6A = 3.25 and 6B =
5.75.
pH = pK - 1og1O[(W, - aB)/(A - 6)] (1)
Here, pK describes the equilibrium, H2PO4- P HPOi + H', and 5A, 6B
are the 31P chemical shifts of the acid and base phosphate forms. As has
been discussed previously, the pH determined by 31P NMR is accurate to
±0.1 and pH changes are accurate to at least ±0.05 (14).
Pulmonary arterial effluent was collected during the NMR experi-
ments and samples were analyzed for lactate and pyruvate concentrations
by standard analytical procedures (15).
Experimental Protocol
NMR data were accumulated in a series of consecutive 4-min time blocks
(3,480 free induction decays) extending over 48 min. Left ventricular
pressure was monitored continuously and midway through each time
block the dp/dt was determined. After termination of each experiment
the hearts were blotted dry, weighed, and heated to constant weight at
1 0°C for determination of tissue water. Sample temperature regulation
was calibrated at 36-370C for each flow rate.
Control hearts (normal flow, 20 ml/min) were followed without
additional perturbation over the full time course. Midway through each
odd time block a sample of pulmonary arterial effluent was obtained.
In the reduced flow studies the perfusate flow was decreased at the end
of the fourth time block (16 min) to either 5 ml/min (25% flow-data not
shown) or 2.5 ml/min (12.5% flow), and then increased to normal flow
(reflow) at the end of the eighth time block (32 min). Hearts were
observed over four additional time blocks after reflow. During the control
and reflow periods of the reduced flow studies the pulmonary arterial
effluent was collected during odd-numbered time blocks; effluent was
collected during each 25% flow time block and (due to insufficient flow)
over both the combined first and second, and third and fourth, 12.5% flow
time blocks. Effluent samples were stored at - 700C prior to lactate and
pyruvate analysis.
In the proceeding discussion the following notation has been adopted.
The term "control study" refers to the group of 14 hearts that were
examined over 48 min with no change in normal perfusate flow rate from
20 ml/min. The term "control period" refers to the 16 min period (four
4-min time blocks) at the start of all studies (control, 25% flow, and 12.5%
flow) in which the perfusate flow was maintained at 20 ml/min. All error
limits are given as standard error of the mean (SEM) unless specifically
indicated to be standard deviation (SD). Statistical significance was
accepted at 95% confidence limits, P < 0.05.
RESULTS AND DISCUSSION
31P NMR Spectra of Isolated Perfused
Rabbit Hearts
A 31P NMR spectrum of a perfused rabbit heart obtained
utilizing the probe and acquisition conditions described in
materials and methods is shown in Fig. 2. Additional
acquisition parameters and identification of resonances are
provided in the figure caption. The apparent frequency
resolution limit is given by the linewidth of the PCr
resonance that averaged 27 Hz for all hearts examined. (In
a later study, a greater emphasis on Bo homogeneity
optimization reduced the average PCr linewidth to 19 Hz.)
Signal-to-noise compares favorably with other previously
published 31PNMR spectra of perfused rabbit heart.
Magnetization Saturation
The directly measured and derived (via TI, vide infra)
magnetization saturation factors are given in Table I and
agree within 9% (excluding GPC). The measured values
were consistently greater than the derived values. Mea-
surement of T, was independent of the saturation factor
measurement as each determination employed a separate
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FIGURE 2 P-31 control period NMR spectrum of a Landendorff-
perfused, isovolumic rabbit heart (-6 g, 370C) at 80.98 MHz. Spectrum
represents 4 min of data averaging (3,480 scans, 100 pulses, 7,463 Hz
spectral width, 1,024 total data points zero filled to 2,048 points, 15 Hz
exponential line broadening filter applied). No proton decoupling was
employed. Intracellular phosphocreatine (PCr) is taken as 0.0 ppm and
IUPAC convention is used to define chemical shifts (8). Peak assign-
ments are: (A) phosphomonoesters (PME); (B) inorganic phosphate (Pi);
(C) glycerophosphorylcholine (GPC); (D) PCr, (0.0 ppm); (E)
y-phosphate of ATP and j#-phosphate of ADP; (F) a-phosphate of ATP
and ADP; shoulder to lower chemical shift is due to NAD; (G)
B-phosphate of ATP. The external reference (trimer) peak is not shown; it
occurs just off scale at 25.3 ppm (see ref. 9).
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TABLE I
MEASURED AND DERIVED SPIN-LATTICE RELAXATION TIMES (T,)
AND MAGNETIZATION SATURATION FACTORS*
Measured saturation Derived Measured Derived Solution
Metabolite resonance factort saturation TTI TIr1vedT(*s(s ± SEM) factor1 (s ± SEM) (s ± SD)
B-phosphate 7.7 ± 0.6 7.4 1.23 ± 0.05 1.5 2.57 ± 0.08
of ATP (n = 11) (n =7) (n* =3)
a-phosphate 8.3 ± 0.2 7.3 1.19 + 0.07 2.0 2.8 ± 0.3
of ATP (n = 11) (n =7) (n* 3)
-y-phosphate 8.8 + 0.4 7.9 1.63 + 0.09 2.4 3.20 + 0.08
of ATP (n= 11) (n= 11) (n* =3)
phosphocreatine 10.7 ± 0.2 9.2 2.7 + 0.2 4.0 8.0 ± 0.4
(n=11) (n-11) (n*=3)
glycerophosphorylcholine 17.0 + 0.6 12.8 5.7 ± 0.51 9.2 8.5 + 1.2
(n = 9) (n= 10) (n* =3)
total inorganic phosphate"l 11.1 ± 0.5 10.4 3.7 + 0.1 4.3 11.6 ± 0.9
(n = 10) (n= 11) (n*= 3)
phosphomonoesters 14.5 + 2.1 7.1
(n= 10)
*Hearts used for T, measurements were not used for saturation factor measurements. Only a single T, or saturation factor measurement was made on a
given heart and these hearts were not used for other experiments. Measurements were made under control perfusate flow conditions, 20 ml/min.
$The measured ratio of the resonance area under slow repetition conditions (900 pulse, T 2 4 T,) to the resonance area under fast repetition conditions
(9.70 pulse, T = 70 ms).
1The ratio of MO to M,y as determined by Eq. 2 substituting T = 70 ms, a = 9.70 and T, = the measured values given in this table.
IMeasured by the BASH saturation recovery method (6, 7) with evolution period cycling.
'Derived from Eq. 2 assuming the ratio of MO to M1y under rapid repetition conditions (T = 70 ms, a = 9.70) is equal to the measured saturation factor.
This is the equivalent of a two-point T, measurement.
**T1 measurements at 370C on a pH = 7.31 physiologic solution of the following composition: PCr 10.6 mM, KCI 150.0 mM, KH2PO4 10.3 mM, GPC
2.0 mM, ATP 5.0 mM, MgSO4 5.1 mM. Value reported is the average of three T, determations (n* = 3) on the same solution.
1$Measured T, distribution was bimodal: 7.1 ± 0.2 (n = 5), 4.2 + 0.3 (n = 5).
11Attempts to determine values for both intra- and extracellular inorganic phosphate were unsuccessful because of insufficient linewidth resolution.
group of rabbits. Thus the concordance between measured
and derived saturation factors supports the accuracy of
these determinations.
Under the conditions employed herein, the exponential
form of the saturation factor (4) can be accurately approxi-
mated as a linear function of TI,
MO 1 -coOa\(T, +cos a 2
M ( T - sin a ,)+ sina' (2)
where advantage was taken of the fact that since the pulse
repetition period T << T, one can approximate exp (-T/
T,) as 1 - (T/T,). For a flip angle of 100 and T = 70 ms
Eq. 2 becomes
MO
- =l 1.3 T, + 5.7. (3)
Mxy
Therefore (as can be seen in Table I), because of the small
slope to intercept ratio a 49% change in the T, of the
y-phosphate ofATP (1.63 to 2.43 s) would result in only an
11% difference in saturation factor (7.9 to 8.8); similarly, a
48% change in the T, of PCr (2.7 to 4.0 s) would result in
only a 16% (9.2 to 10.7) difference in saturation factor.
This moderate dependence of saturation factor on T,
under the rapid repetition conditions employed herein has
two important ramifications. First, small errors in mea-
sured saturation factor lead to large errors in T, derived
from such measurements as in Table I. Second, one would
have to postulate major changes in T, and/or in the rates of
chemical exchange modulation of effective T, to markedly
change the degree of magnetization saturation during the
course of an experiment. No evidence of such change was
seen during the course of study described herein. Neverthe-
less, it remains an important assumption of this rapid pulse
repetition methodology that saturation factors determined
under control conditions remain constant or undergo minor
change relative to metabolite concentration changes under
noncontrol conditions.
The metabolite T, values of a physiologic solution,
shown for comparison in Table I, are all substantially
greater (100-200%) than those of the perfused rabbit
heart. This may be due to the presence of cytosolic
paramagnetic ions, exchange between bound (immobile)
and free (mobile) metabolites, or perhaps substantial
differences in viscosity.
Lineshape Analysis
Four separate spectral regions of all 31P spectra were
independently fit, each to a sum of Lorentzian lines plus a
single straight line. Fitted regions were chosen such that
the resonance intensities were just above the noise level at
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the region's frequency limits. The result of a multipara-
meter Lorentzian lineshape analysis of the 31P spectrum
shown in Fig. 3 a is given in Fig. 3 b, where the calculated
lineshapes have been substituted into the original spectrum
within the fitted regions only. Potential primary sources of
error include both deviations from true Lorentzian line-
shape and incorrect phasing of the spectrum (i.e., disper-
sive in addition to absorptive components). Quantitative
comparison between fitted and experimental data is shown
in Fig. 3 c (i.e., the difference spectrum of Fig. 3 a minus
Fig. 3 b). Deviations from an ideal fit are small, typically
of the same intensity as the noise level in the original data.
In fact, had the entire theoretical spectrum been sub-
tracted (as opposed to the specifically fitted regions), the
errors in the lineshape analysis would not have been
discernable from the background noise. Comparison of
other randomly chosen spectra gave similar results. Thus,
the use of a Lorentzian lineshape analysis is justified.
Further justification may be found in the close agreement
in ATP concentration whether determined independently
from the ,3-phosphate or the y-phosphate resonance area
(i.e., a difference between the two determinations of 0.1 ±
0.1 utmol/g-wet-weight (n = 160), vide infra).
Phosphorus Metabolites
The control period concentrations of ATP, PCr, Pi, and
GPC were 3.23, 5.98, 1.04, and 2.08 ,umol/g-wet-weight
(Table II). Resolution of the intra- and extracellular Pi
resonances was not sufficient for separate quantitative area
determination of each component. For comparison, Table
III lists the values of total ATP, PCr, and ADP determined
independently by other researchers using freeze-extraction
techniques with in vitro perfused rabbit heart (16-21).
ATP and PCr concentrations determined by NMR fall
in the upper range of freeze extraction derived concentra-
tions. This possibly results from the documented deleteri-
ous effects of the finite freezing time on high energy
phosphorus metabolite levels using Wollenberger clamps
LORENTZIAN LINESHAPE ANALYSIS
a
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FIGURE 3 Results of a Lorentzian lineshape analysis of a control period
heart spectrum. The original experimental spectrum is shown in a.
Specific spectral regions were then defined along with the number of
peaks in each region and estimates of the peaks' position, height, and
width; a nonlinear least-squares lineshape analysis was then performed
for each region and the resulting lineshape (i.e. simulated spectrum)
substituted back into the original spectrum within the previously defined
spectral regions (b). A difference spectrum, a - b = c, shown in c
illustrates the quality of the fit. Errors in the curve fitting are within the
original baseline noise.
(22). Our inability to directly measure ADP concentra-
tions by 31P NMR, 0.1 ± 0.1 tmol/g-wet-weight (n = 160)
(taken as the difference between the concentrations deter-
mined from the resonances at - 2.5 ppm (nucleoside di-
and triphosphates) and -16 ppm [nucleoside triphos-
phates]) suggests that the substantial amounts of ADP
detected by freeze-extraction (-0.5 ,gmol/g-wet-weight;
Table III) represent either a bound, immobilized pool or an
artifact of finite freezing times (1).
TABLE II
CONTROL PERIOD MOBILE METABOLITE CONCENTRATIONS AS DETERMINED BY 31P NMR
Metabolite
ATP PCr Pi GPC ADP* pHt
(n= 160) (n = 160) (n = 35) (n = 35) (-) (n = 77)
/imol/g-wet-weight: 3.23 5.98 1.04w 2.08 0.0171 7.03
0.0121
±SEM ±0.05 ±0.10 ±0.19 ±0.23 0.01
cytosolic I mM: 8.08 14.95 2.61 5.20 0.042
0.030
±SEM ±0.13 ±0.25 ±0.47 +0.58 -
*Derived two different ways from consideration of the creatine kinase equilibrium reaction; see text.
tIntracellular pH.
Value represents cytosolic Pi only; see text.
1Values represents cytosolic ADP only; see text.
'Derived values of actual intracellular cytosolic concentrations; see text.
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TABLE III
TOTAL IN VITRO PERFUSED* RABBIT HEART TISSUE METABOLITE CONCENTRATIONS AS DETERMINED BY
FREEZE-CLAMPING AND CHEMICAL ANALYSIS
Amol/g-wet-weight ± SEM
Reference
ATP ADP PCr
2.75 ± 0.27 0.46 ± 0.05 5.54 ± 0.17 Lee and Visscher (16)t
(n =5) (n =5) (n =6)
2.67 + 0.14 6.62 + 0.30 Thomas et al. (17)*
(n =8) (n 8)
3.55 + 0.24 0.57 + 0.09 Richman and Wyborny (18)1
(n =6) (n =6)
2.66 + 0.22 Aussedat and Rossi (19)$
(n = 4)
2.62 ± 0.26 0.48 ± 0.05 Liu and Feinberg (20)$
(n =6) (n 6)
2.89 ± 0.19 5.15 ± 0.25 Nayler et al. (21)$
(n =6) (n 6)
*Perfusion media were not reported to contain insulin.
tData originally presented as ,umol/g-dry-weight and converted to gsmol/g-wet-weight by dividing by the wet to dry weight ratio determined in the
current investigation for control study hearts: 6.37 ± 0.19 (n = 14).
1Data originally presented as,umol/g-wet-weight.
Reduced Flow Conditions
Reduction of perfusate flow resulted in significant PCr, Pi,
and H+ concentration changes compared with the control
study (Fig. 4). The PCr concentration decreased 69% from
6.5 ± 0.4 to a plateau level of 2.0 ± 0.4 ,umol/g-wet-weight
after 16 min of reduced flow. The H+ concentration
rapidly increased 2.6-fold from pH 7.01 ± 0.03 to 6.60 +
0.03. Total inorganic phosphate concentration increased
from 4.0 ± 0.3 to 9.5 ± 0.8 ,tmol/g-wet-weight. This
corresponds to a 6.5-fold increase in cytosolic inorganic
phosphate (vide infra) from 1.0 ± 0.3 to 6.5 ± 0.8
,4mol/g-wet-weight. After 16 min of reflow the PCr, Pi,
and H+ levels returned to control period values: PCr 6.8 +
0.4 Amol/g-wet-weight, pH 7.00 ± 0.03, total P. 4.2 + 0.3
,mol/g-wet-weight. A similar pattern of change to a new
steady-state level during reduced flow with subsequent
return toward control period levels after reflow was mir-
rored in the left ventricular developed pressure, peak
dp/dt, and pulmonary arterial effluent lactate and pyru-
vate concentrations (Fig. 5). However the recovery of
hemodynamic parameters appeared to lag behind the rapid
recovery of the metabolic indices (i.e., PCr, Pi, H+, lactate,
pyruvate). None of the metabolic or hemodynamic param-
eters, including PCr concentration, exhibited any marked
overshoot of control period values after reflow. Phospho-
creatine concentration overshoot immediately after recov-
ery from zero flow has been reported previously (23-30).
The effect of reduced flow upon ATP levels was much
less than for the other metabolites, as expected from
consideration of the creatine kinase reaction. After 16 min
of reduced flow ATP concentrations dropped from 3.3 +
0.1 to 2.4 ± 0.2 ,umol/g-wet-weight a decrease of 27%.
This decrease was significantly different from the control
study. Subsequent reflow gradually returned values toward
control levels but after 16 min ATP had not returned to
control concentrations.
The decrease in the sum of ATP and PCr levels was
precisely matched by the increase in Pi during reduced
flow, - 5.4 and + 5.5 ,umol/g-wet-weight respectively. This
is consistant with PCr and ATP hydrolysis as the primary
source of Pi.
The GPC resonance was located in a region of great
peak overlap. However, a previous comparison from this
laboratory of freeze-clamp wet-chemical analysis of GPC
concentration with NMR analysis, using control period
hearts not employed in this study, showed no significant
difference between the GPC levels determined by either
method (31). In this study glycerophosphorylcholine levels
appeared to decrease during reduced flow from 1.8 ± 0.1 to
1.3 ± 0.2 ,4mol/g-wet-weight (0.1 < p < 0.2).
As can be seen from Figs. 4 and 5, metabolite levels, pH,
and hemodynamic parameters were quite stable over 48
min in the control study and in the 16 min control periods
prior to the reduced flow studies. Compared with the
control study the values of all observables in the control
periods of the reduced flow studies were not significantly
different.
Derived Cytosolic Concentrations
The directly measured metabolite concentrations are
determined by 31P NMR as total (mobile) moles per wet
weight of tissue, however, these values can be converted to
intracellular cytosolic concentrations. Nayler et al. (32)
and others (33-35) have shown that .60% of the tissue
volume of a buffer perfused rabbit heart is intracellular
space, and furthermore, that -20% can be attributed to
mitochondrial space. Thus, assuming a density of 1 gram/
ml, 40% of the tissue wet-weight in grams represents the
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FIGURE 4 Mean metabolite concentrations determined by 31P NMR under control, reduced flow and reflow periods. Phosphocreatine (PCr)
and adenosine triphosphate (ATP) are reported, as measured, in micromoles per gram-wet-weight. Inorganic phosphate (Pi) is reported as
millimolar cytosolic Pi to stress its derivation from measured total Pi; this can be converted to cytosolic Pi per gram-wet-weight by multiplying
by 0.4 (see text for details). Intracellular H+ concentration is reported in pH units and was determined from the Pi chemical shift. The arrows
indicate the reduction of flow at 16 min and the return to control flow at 32 min for the 12.5% (2.5 ml/min) flow study, n = 14. There was
no reduction of flow during the control study (20 ml/min), A, n = 14. Standard error of the mean is indicated by 0 and significant deviation
(P < 0.05) from the control study is denoted by *.
nonmitochondrial intracellular cytosolic volume in millili-
ters. Given that the observed ATP, PCr, and GPC are
primarily cytosolic intracellular metabolites, this conver-
sion is straightforward. Control period cytosolic concentra-
tions of ATP, PCr, and GPC are 8.08, 14.95, and 5.20mM
respectively (Table II).
The Pi concentration obtained from 31P NMR contains
contributions from not only intracellular, interstitial, and
vascular spaces, but also a contribution from the perfusion
medium surrounding the heart. Since, to a good approxi-
mation, small ions are equally distributed between intersti-
tial and vascular space (36), one may reasonably approxi-
mate interstitial and vascular Pi concentrations as 1.2 mM,
equal to that of the perfusion medium. With this assump-
tion, and given the previously discussed compartment
volume distribution and the sensitive volume of the NMR
probe (19.6 ml), the intracellular cytosolic Pi concentration
can be derived. The control period value is 2.61 mM (Table
II).
Attempts to measure ADP concentration directly by 31p
NMR failed (vide supra). However, a free cytosolic ADP
concentration can be derived from consideration of the
creatine kinase reaction. Work of several groups supports
an equilibrium model for the creatine kinase reaction in
heart (37-40) and other tissue (41, 42). Utilizing the
known equilibrium constant for the creatine kinase reac-
tion, 5.5 x 10- (43), and the known total creatine pool
concentration, 24.5 mM (17)', the derived cytosolic ADP
concentration is 30,uM.
'Data originally presented as ,umole/g-dry-weight. Converted to milli-
moles per liter by dividing by the wet-to-dry-weight ratio (see footnote b
in Table III) and dividing by 0.4 to account for the 40% cytosolic volume.
See text for details.
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Alternatively, the mass action expression can be rear-
ranged to yield a linear formulation, Eq. 4, given an
equilibrium model with the following assumptions: (a) the
equilibrium constant has the previously cited value (43);
(b) the cytosolic free (unbound) ADP concentration is
constant; and (c) the total free cytosolic pool of creatine
plus phosphocreatine (TCP) is constant.
[H+] [TCP] 1
(5.5 x 10-'°)[ATP] [ADP][PCr] [ADP]
A plot of [H+]/(5.5 x 10-')[ATP] as a function of
[PCr]-' is then predicted to yield an intercept of
- [ADP] - 1 and a slope of [TCP]/ [ADP]. Thus, this model
not only predicts a linear formulation, Eq. 4, but provides a
measure of the free cytosolic ADP concentration, i.e.,
- (intercept)-', and a measure of the total pool of creatine
plus phosphocreatine, i.e., - slope/intercept. Using the
mean cytosolic concentrations derived from the 25% flow
study for H+, ATP, and PCr, Eq. 4 yields a linear
correlation factor (r) of 0.88 (n = 12, P < 0.001), [ADP] =
0.042 mM, and [TCP] = 26.2 mM. This ADP concentra-
tion compares favorably with the 0.030 mM derived above
as does the total creatine pool with the previously cited
value directly measured in rabbit heart by Lee and
Visscher (16).
These results support the validity of the proposed
"linear" creatine kinase equilibrium model under control
and 25% flow conditions. It should be noted that the (two)
data points that lie most clearly off the linear regression
line represent time blocks 5 and 9, namely, the initial 4 min
of reduced flow and the initial 4 min of reflow. These time
blocks represent periods of dramatic, rapid metabolic and
hemodynamic flux (Figs. 4 and 5). Thus, it is not surpris-
ing that the proposed equilibrium model is least satisfac-
tory during intervals of change between steady-state condi-
tions. However, this model did not agree well with the
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12.5% flow study data suggesting that the creatine kinase
reaction may not rapidly return to equilibrium and/or that
the free ADP concentration does not remain constant after
dramatic reductions in substrate delivery.
A parameter of substantial importance in cellular
energy regulation is the free energy of ATP hydrolysis at
pH = 7 (AG'), Eq. 5,
AG' = AGO' + RTln [ADP][Pi] (5)[ATPJ
Using the cytosolic concentrations of ATP, ADP, and Pi
given in Table II and a AGO' value of -31.8 KJ/mol from
Lawson and Veech (44) one derives AG' = -60.7 KJ/mol.
This is similar but somewhat higher than AG' values of
- 53.6 KJ/mol and - 58.8 KJ/mol previously reported for
perfused rat heart (45, 46) primarily due to the small ADP
concentration.
The low concentrations of mobile ADP (0.030 and 0.042
mM) are certainly well below 31P NMR detection limits in
perfused heart and are consistent with our inability to
directly measure ADP levels (vide supra). These concen-
trations are very close to the experimentally determined
values of the Michaelis constant (KM,@) of ADP for
respiratory stimulation (47-49). Strong evidence has been
presented (47-49) that respiratory rates can be influenced
by the concentration of extramitochondrial ADP and the
kinetics of its transport. It has been previously pointed out
that the similarity between the derived values for the free
concentration of ADP and the reported values of the KM,,P
suggests an important regulatory role for this molecule in
myocardial respiration (29).
Independent Hemodynamic and
Biochemical Indices
Motivated by the potential future clinical application of 31P
NMR for diagnosis and management of cardiovascular
disease, strong correlates between NMR derived metabo-
lite concentrations (i.e., ATP, PCr, Pi, and H+) and
accepted traditional indices of heart function (i.e., LVDP,
LVP, dp/dt, lactate, and lactate/pyruvate ratio) are noted.
Considering both reduced flow experiments, PCr and Pi
concentrations correlated extremely well with all hemody-
namic parameters a r 2 0.96). Furthermore, the Pi con-
centration correlated very closely with lactate level and the
lactate:pyruvate ratio a r > 0.97) while PCr concentration
showed a more moderate relationship lr 2 0.92). The
proton concentration showed a greater correlation with the
hemodynamic parameters, lactate concentration, and lac-
tate/pyruvate ratio in the 25% flow experiment (Irl 2
0.87) than in the 12.5% flow experiment a r I 2 0.69). The
slow rate of ATP decline in the presence of rapid hemody-
namic deterioration resulted in a poor correlation of ATP
concentration with the hemodynamic and pulmonary arte-
rial effluent parameters in both the 25% flow experiment
(I r 2 0.45) and the 12.5% flow experiment r_ 2 0.62).
Therefore, given the entire time period of the reduced flow
model presented herein, one can rank the NMR-derived
metabolite concentrations as indices of cardiac function in
order of strong to weak linear correlates as PCr t Pi >
H»>> ATP.
Summary
Quantitative phosphorus metabolite analysis has been per-
formed on isovolumic Langendorff-perfused rabbit hearts
by 31P NMR. The salient features of this model were as
follows. (a) Blood anticoagulant and chemical anesthesia
were not employed; animals were stunned prior to heart
excision. (b) The perfusion medium was EDTA free but
did contain insulin and inorganic phosphate. (c) 16-min
periods of reduced perfusate flow (20 ml/min reduced to 5
or 2.5 ml/min) were used in contrast to periods of zero flow
(i.e., "global ischemia"). (d) Hearts were continuously
paced at 180 beats/min throughout all experiments includ-
ing reduced-flow periods. (e) Hemodynamic, and pulmo-
nary arterial effluent lactate and pyruvate measurements
were made concomitantly with NMR data collection on all
hearts. (f) A complete protocol of control experiments
was carried out and analyzed in full over the entire
experimental time course. (g) Resonance peak areas were
determined by Lorentzian lineshape analysis and con-
verted to concentration units by consideration of magneti-
zation saturation and reference to an external standard.
The NMR derived ATP and PCr concentrations agree
well with those derived by chemical extraction. However,
at variance with extract results, NMR derived ADP levels
are extremely low. Excellent linear correlations are
observed between the phosphorus metabolite levels and
independent hemodynamic and biochemical indices of
myocardial function. The quantitative 31P NMR experi-
ment is, thus, a sensitive monitor of myocardial compe-
tence and, therefore, 31P NMR can potentially provide
information to facilitate the clinical evaluation and man-
agement of cardiovascular disease.
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